Chris Kuehn (@chris_kuehn) 's Twitter Profile
Chris Kuehn

@chris_kuehn

Father and microbiologist from South Dakota living in SoCal via WA

ID: 602091943

calendar_today07-06-2012 18:23:51

119 Tweet

27 Takipçi

134 Takip Edilen

Peter Kolchinsky (@peterkolchinsky) 's Twitter Profile Photo

Some think patents stand in way of making more vaccines. They don’t. Skill & money do. Just as most of us couldn’t replicate Mona Lisa (no IP there), few can make advanced vaccines. Vaccine companies have already partnered w/ all skilled producers they could find to make doses.

Some think patents stand in way of making more vaccines. They don’t. Skill & money do. Just as most of us couldn’t replicate Mona Lisa (no IP there), few can make advanced vaccines. Vaccine companies have already partnered w/ all skilled producers they could find to make doses.
Bob Wachter (@bob_wachter) 's Twitter Profile Photo

An really smart idea to encourage vaccinations: Report hospitalizations & deaths (both local & nationally) in 2 categories: in vaccinated people vs. in unvaccinated people. It would take about 10 minutes for benefits of vaccination to be obvious. (H/T to UC San Francisco's Matt Springer)

Amy Schneider (@jeopardamy) 's Twitter Profile Photo

I’d like to thank all the people who have taken the time, during this busy holiday season, to reach out and explain to me that, actually, I’m a man. Every single one of you is the first person ever to make that very clever point, which had never once before crossed my mind 🙏

ArtivaBio (@artivabio) 's Twitter Profile Photo

Artiva Biotherapeutics Announces FDA Allowance of IND for AB-201, a HER2-Targeted CAR-NK for the Treatment of Solid Tumors artivabio.com/artiva-biother… #sandiego #biotech #nkcell #nkcells #nkcelltherapy #cancer #oncology

Artiva Biotherapeutics Announces FDA Allowance of IND for AB-201, a HER2-Targeted CAR-NK for the Treatment of Solid Tumors

artivabio.com/artiva-biother… 

#sandiego #biotech #nkcell #nkcells #nkcelltherapy #cancer #oncology
ArtivaBio (@artivabio) 's Twitter Profile Photo

We’re honored to be recognized in the 2023 #PM360InnovationsIssue for advancing the first allogeneic NK cell therapy to #clinicaltrials for the #autoimmunedisease #lupus nephritis. pm360online.com/pm360-2023-inn… #NKcells #AlloNK

We’re honored to be recognized in the 2023 #PM360InnovationsIssue for advancing the first allogeneic NK cell therapy to #clinicaltrials for the #autoimmunedisease #lupus nephritis.

pm360online.com/pm360-2023-inn…

#NKcells #AlloNK
ArtivaBio (@artivabio) 's Twitter Profile Photo

On this pharmaphorum podcast, Artiva’s CEO discusses the potential of #NKcells as an allogeneic #celltherapy approach in #autoimmunedisease and the importance of a robust manufacturing process. pharmaphorum.com/oncology/move-… #AlloNK #lupus

Gareth Harney (@optimoprincipi) 's Twitter Profile Photo

📚 Signed Book Giveaway! 🪙 To celebrate the release of Moneta: A History of Ancient Rome in Twelve Coins, I'm giving away 3 signed and personalised copies. Simply retweet this post to enter. Winners will be chosen on Friday 14th June. Open worldwide. Bona Fortuna! ⚔️

📚 Signed Book Giveaway! 🪙

To celebrate the release of Moneta: A History of Ancient Rome in Twelve Coins, I'm giving away 3 signed and personalised copies. Simply retweet this post to enter. Winners will be chosen on Friday 14th June. Open worldwide.

Bona Fortuna! ⚔️
Robert Sterling (@robertmsterling) 's Twitter Profile Photo

Let’s say a scientist invents a product that costs $5 per unit to mass produce—just five bucks for the raw materials and the direct labor costs of manufacturing it. What’s a fair price to charge? Should she be allowed to charge $10, for a 50% gross margin? What about charging

Let’s say a scientist invents a product that costs $5 per unit to mass produce—just five bucks for the raw materials and the direct labor costs of manufacturing it.

What’s a fair price to charge? Should she be allowed to charge $10, for a 50% gross margin? What about charging